A 23-year-old woman from Scotland is speaking out about the devastating health consequences of ketamine addiction after years of recreational drug use left her with severe bladder damage, urinary incontinence, and the need for regular Botox injections into her bladder.
Ellie Wight says she began using ketamine at age 18 and developed an addiction that lasted five years. During that time, she spent thousands of dollars on the drug and experienced worsening urinary symptoms that she initially mistook for recurring infections. By the time doctors identified the cause, her bladder had suffered significant and potentially permanent damage.
Her experience comes as healthcare professionals in the United Kingdom report growing concerns about ketamine-related bladder injuries, particularly among young people.
According to Natural Medicine of Library, ketamine is a dissociative anesthetic used medically for anesthesia, pain management, and certain mental health conditions. Recreational misuse of the drug can produce hallucinogenic effects and has been associated with severe health complications, including bladder damage.
Wight's health problems developed gradually as her ketamine use continued. She began experiencing severe bladder pain and noticed blood and mucus in her urine. Despite these warning signs, she did not immediately connect the symptoms to ketamine use.
Her condition eventually became so serious that she was hospitalized with a kidney infection. Further medical examinations revealed extensive damage to her urinary system.
According to reports, her bladder capacity shrank to approximately 100 milliliters. A healthy bladder typically holds 300–600 ml of urine, but Ellie told BBC her bladder capacity has been reduced to just 50–100 ml. The reduction in capacity left her struggling with constant urgency, frequent trips to the bathroom, and urinary incontinence.
Wight said she initially mistook her symptoms for recurring UTIs, but was later hospitalized with a kidney infection. She experienced blood in her urine, severe bladder pain, and episodes of incontinence, describing the pain as intense and debilitating.
Although Wight has since stopped using ketamine and remains committed to her recovery, doctors have told her that some of the damage may be irreversible.
Public discussion about ketamine intensified after the death of Matthew Perry in October 2023. The actor died from the acute effects of ketamine, according to the Los Angeles County Medical Examiner, bringing renewed attention to a drug that has both legitimate medical uses and a growing presence in recreational settings.
Ketamine-induced cystitis is a chronic inflammatory condition of the bladder linked to long-term ketamine use. First reported in 2007, the condition has become increasingly recognized among regular recreational users. Patients often experience severe urinary symptoms that can significantly affect their quality of life.
Researchers believe ketamine and its metabolites are excreted through the urine, where they may directly irritate the urinary tract. This exposure can trigger inflammation, damage the bladder lining, and eventually lead to scarring and reduced bladder function.
People with ketamine-induced cystitis often develop symptoms similar to those of a urinary tract infection. These may include urinary frequency, urgency, painful urination, blood in the urine, pelvic pain, and difficulty holding urine. Symptoms can become progressively worse with continued ketamine use.
As Ellie Wight's experience illustrates, the effects of ketamine addiction can extend far beyond substance dependence, leaving lasting physical consequences that may persist for years after sobriety.
Wight said she hopes sharing her experience will raise awareness of ketamine's risks, support recovery services, and encourage others to seek help.
References:
1. H.-W. Chu, Y.-J. Lin, Y.-C. Hsu, and H.-L. Chen, “Ketamine Use Disorder: What We Know and What We Need to Know,” Neuropsychiatric Disease and Treatment 19 (2023): 2937–2951,
https://pmc.ncbi.nlm.nih.gov/articles/PMC10820504/
2. Shalom Srirangam and Joe Mercer, “Ketamine Bladder Syndrome: An Important Differential Diagnosis When Assessing a Patient with Persistent Lower Urinary Tract Symptoms,” BMJ Case Reports (2014),
